Repare Therapeutics Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINESCHEDULE 13G/ARepare Therapeutics Inc.RPTXMay 14

   Ownership stake disclosure by Blue Owl Capital Holdings LP (amended)

   Blue Owl Capital Holdings LP, filed by

2. ROUTINE15-12GRepare Therapeutics Inc.RPTXFeb 19

   Deregistration notice

3. ROUTINEEFFECTRepare Therapeutics Inc.RPTXFeb 2

   Registration declared effective

4. ROUTINE4Repare Therapeutics Inc.RPTXJan 30

   BIOTECHNOLOGY VALUE FUND L P, insider filing for RPTX

   BIOTECHNOLOGY VALUE FUND L P, reporting · BVF PARTNERS L P/IL, reporting · +8 more

5. NOTABLESCHEDULE 13D/ARepare Therapeutics Inc.RPTXJan 30

   Ownership stake disclosure by BIOTECHNOLOGY VALUE FUND L P (amended)

   BIOTECHNOLOGY VALUE FUND L P, filed by

6. ROUTINE4Repare Therapeutics Inc.RPTXJan 28

   5 insider filings

   Carol Schafer, insider filing for RPTX

   Show all 5

   • 4Insider filing for RPTXJan 28
   • 4Insider filing for RPTXJan 28
   • 4Insider filing for RPTXJan 28
   • 4Insider filing for RPTXJan 28
   • 4Insider filing for RPTXJan 28

   Carol Schafer, reporting

7. ROUTINES-8 POSRepare Therapeutics Inc.RPTXJan 28

   S-8 POS filing

8. ROUTINES-8 POSRepare Therapeutics Inc.RPTXJan 28

   S-8 POS filing

9. ROUTINES-8 POSRepare Therapeutics Inc.RPTXJan 28

   S-8 POS filing

10. ROUTINES-8 POSRepare Therapeutics Inc.RPTXJan 28

    S-8 POS filing

11. ROUTINES-8 POSRepare Therapeutics Inc.RPTXJan 28

    S-8 POS filing

12. ROUTINES-8 POSRepare Therapeutics Inc.RPTXJan 28

    S-8 POS filing

13. ROUTINES-8 POSRepare Therapeutics Inc.RPTXJan 28

    S-8 POS filing

14. ROUTINES-8 POSRepare Therapeutics Inc.RPTXJan 28

    S-8 POS filing

15. ROUTINEPOS AMRepare Therapeutics Inc.RPTXJan 28

    POS AM filing

16. ROUTINE8-KRepare Therapeutics Inc.RPTXJan 28

    Current report

17. NOTABLE25-NSERepare Therapeutics Inc.RPTXJan 28

    Delisting notice

    Nasdaq Stock Market LLC, filed by

18. ROUTINESCHEDULE 13GRepare Therapeutics Inc.RPTXJan 27

    Ownership stake disclosure by Shay Capital LLC

    Shay Capital LLC, filed by

19. ROUTINE8-KRepare Therapeutics Inc.RPTXJan 16

    Current report

20. ROUTINEDEFA14ARepare Therapeutics Inc.RPTXDec 29, 2025

    Additional proxy materials

21. ROUTINE8-KRepare Therapeutics Inc.RPTXDec 29, 2025

    Current report

22. ROUTINEDEFA14ARepare Therapeutics Inc.RPTXDec 19, 2025

    Additional proxy materials

23. ROUTINE8-KRepare Therapeutics Inc.RPTXDec 19, 2025

    Current report

24. NOTABLEDEFM14ARepare Therapeutics Inc.RPTXDec 15, 2025

    Merger proxy statement

25. ROUTINEDEFA14ARepare Therapeutics Inc.RPTXDec 15, 2025

    Additional proxy materials

26. NOTABLEPREM14ARepare Therapeutics Inc.RPTXDec 3, 2025

    PREM14A filing

27. NOTABLESCHEDULE 13D/ARepare Therapeutics Inc.RPTXNov 24, 2025

    Repare Therapeutics Inc. filed SCHEDULE 13D/A

    • Form Type: SCHEDULE 13D/A
    • Filing Date: 2025-11-24

    BIOTECHNOLOGY VALUE FUND L P, filed by

28. NOTABLESCHEDULE 13D/ARepare Therapeutics Inc.RPTXNov 21, 2025

    Repare Therapeutics Inc. filed SCHEDULE 13D/A

    • Form Type: SCHEDULE 13D/A
    • Filing Date: 2025-11-21

    Versant Venture Capital V, L.P., filed by

29. ROUTINEDEFA14ARepare Therapeutics Inc.RPTXNov 20, 2025

    Repare Therapeutics Inc. filed DEFA14A

    • Form Type: DEFA14A
    • Filing Date: 2025-11-20
30. NOTABLE10-QRepare Therapeutics Inc.RPTXNov 14, 2025

    Quarterly report

31. ROUTINEDEFA14ARepare Therapeutics Inc.RPTXNov 14, 2025

    Additional proxy materials

32. ROUTINE8-KRepare Therapeutics Inc.RPTXNov 14, 2025

    Current report

Older filings on EDGAR